Biotech-Sance SPRL
Dissolution volontaire – liquidationBiotech-Sance reported total assets of 33,666 € at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Dec 2025).
The score of Biotech-Sance shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -12 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Biotech-Sance's annual accounts
Filed annual accounts
- Year ended 31 Mar 2025filed on 27 Dec 2025
- Year ended 31 Mar 2024filed on 27 Dec 2025
- Year ended 31 Mar 2023filed on 26 Dec 2025
- Year ended 31 Mar 2022filed on 26 Dec 2025
- Year ended 31 Mar 2021filed on 23 Dec 2025
Biotech-Sance's financial analysis
- Solvency-1477.6%sector median: 58.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Biotech-Sance
Biotech-Sance's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0830.539.041
- VAT number
- BE0830539041
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SPRL
- Incorporated
- 22 Oct 2010
- Registered office
- 4130 Esneux
- Latest accounts
- 2025 · filed on 27 Dec 2025
- Activity
- Activities in the field of nutrition (NACE 86995)
Biotech-Sance (SPRL) has been based in Esneux since 2010, active in: activities in the field of nutrition. For 2025, it reports a net loss of 782 € and equity of −497,456 €; its revenue is not published. Its solvency stands at -1477.6%, below the median of its sector (58.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Biotech-Sance
Companies in the same business, of comparable size and area, outside its group.
- Kevin Goussens Sports and recreation education Fernelmont · balance sheet 23,381 €
- Haptis Other human health activities n.e.c. Ramillies · balance sheet 388,268 €
- Matth Other human health activities n.e.c. De Panne · balance sheet 50,736 €
- Q Care Medical Services Other human health activities n.e.c. Diepenbeek · balance sheet 96,876 €
- Op Wieltjes Other human health activities n.e.c. Ranst · balance sheet 104,574 €
- Dokter Liene Eysermans General medical practice activities Leuven · balance sheet 59,317 €
- Optibrein Other human health activities n.e.c. Scherpenheuvel-Zichem · balance sheet 15,965 €
- Dr. Wouter L’Hoyes Medical specialists activities Herent · balance sheet 40,455 €
Frequently asked questions about Biotech-Sance
What is the revenue of Biotech-Sance?
Biotech-Sance files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Biotech-Sance?
In Belgium, the VAT number is the company number prefixed with BE: BE0830539041 for Biotech-Sance, if the company is VAT-registered. Its company number (CBE) is 0830.539.041.
Where is the registered office of Biotech-Sance?
According to the CBE register, the registered office of Biotech-Sance is in 4130 Esneux.
What is the equity of Biotech-Sance?
At the close of the 2025 financial year, the equity of Biotech-Sance amounts to -497,456 €, a solvency of -1477.6% of total assets.
Who manages Biotech-Sance?
The register lists 2 active mandates at Biotech-Sance. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Biotech-Sance
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →